Completion of the TRYPTIK®2 C-PLATE study

Spineart is delighted to announce that the TRYPTIK®2 C-Plate study has been recently completed with 42 patients enrolled!

These patients were treated with TRYPTIK®2 C-Plate Anterior Cervical Plate System between 2018 and 2020 in Spain, and retrospective/prospective data were collected to at least 1 year post surgery as per standard practice, to support the clinical safety, performance, and benefit of our device. 

We would like to thank Dr. Garcia from the Hospital Clínico Universitario de Valencia, as well as his team, for their involvement and dedication to this clinical study.

Dr. Garcia on the TRYPTIK®2 C-Plate: “TRYPTIK®2 C-Plate is easy to use and ensure a very good stability”.

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporativo
  For the fifth consecutive year, Spineart is proud to support our ANZ distributor, Life Healthcare, in its charitable mission to Cambodia. Spineart provides all the implants and instruments required...
  • Innovación
Geneva, Switzerland, August 26, 2026 – Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted...
  • BAGUERA® C
Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...